Magomet Aushev

Dr. Magomet Aushev

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SOSara Cuevas Ocana
Sara Cuevas Ocana
JYJin Ye Yang
Jin Ye Yang
MAMagomet Aushev
Magomet Aushev
GSGeorge Schlossmacher
George Schlossmacher
CBChristine Bear
Christine Bear
Michael GrayMichael Gray
Michael Gray
Introducing or correcting disease-causing mutations through genome editing in human pluripotent stem cells (hPSCs) followed by tissue-specific differentiation provide sustainable models of multiorgan diseases, such as cystic fibrosis (CF). However, low editing efficiency resulting in extended cell culture periods and the use of specialised equipment for fluorescence activated cell sorting (FACS) make hPSC genome editing still challenging. We aimed to investigate whether a combination of cell cycle synchronisation, single-stranded oligodeoxyribonucleotides, transient selection, manual clonal isolation, and rapid screening can improve the generation of correctly modified hPSCs. Here, we introduced the most common CF mutation, ΔF508, into the CFTR gene, using TALENs into hPSCs, and corrected the W1282X mutation using CRISPR-Cas9, in human-induced PSCs. This relatively simple method achieved up to 10% efficiency without the need for FACS, generating heterozygous and homozygous gene edited hPSCs within 3–6 weeks in order to understand genetic determinants of disease and precision medicine.

8 July 2020 in Nature
Verified
Journal Article
Closed access
MAMagomet Aushev
Magomet Aushev
MHMary Herbert
Mary Herbert